SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natco Pharma informs about allotment of equity shares of ESOS

28 Jan 2022 Evaluate

Natco Pharma has informed that the Compensation Committee of the Board of Directors of the Company has allotted 1,55,000 equity shares of Rs 2 each (Face Value) on 28th January, 2022 by way of resolution passed by circulation to the eligible employees who had exercised their vested options under the Company's Employee Stock Option Scheme, 2017 (ESOS). The said equity shares shall rank with the existing equity shares of the Company in all respects including dividends and corporate benefits, if any, to be declared by the Company. Resultantly, the paid-up share capital of the Company will be Rs 36,50,40,330 divided into 18,25,20,165 equity shares of Rs 2 each.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

1118.95 31.25 (2.87%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×